Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

• Autori principali: Craig M Smith (Autore), Andrew W Walker (Autore), Ihaia T Hosken (Autore), Berenice E Chua (Autore), Cary eZhang (Autore), Mouna eHaidar (Autore), Andrew L Gundlach (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2014-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Animal and clinical studies of gene-environment interactions have helped elucidate the mechanisms involved in the pathophysiology of several mental illnesses including anxiety, depression and schizophrenia; and have led to the discovery of improved treatments. The study of neuropeptides and their re...